文献速递青光眼

改善青光眼用药依从性的干预措施:随机对照试验的网络Meta分析

Interventions for Glaucoma Medication Adherence Improvement: A Network Meta-analysis of Randomized Controlled Trials.
PubMed 文献 · Ophthalmology · 2022-08-23

该网络Meta分析纳入19项RCT(4981例参与者),比较11类干预对青光眼用药依从性的效果。与标准治疗相比,定制化护理(SMD 1.28;95%CI 0.08-2.48)及包含定制化护理的多组分干预可改善依从性,其中定制化护理+多媒体教育+设备提醒的P-score最高(0.914)。作者认为定制化护理可改善依从性,多组分方法可能带来额外改善。

要点

  • 定制化护理优于标准治疗(SMD 1.28;95%CI 0.08-2.48;P-score 0.810)。
  • 定制化护理+多媒体教育SMD 1.44(95%CI 0.20-2.67;P-score 0.850)。
  • 定制化护理+多媒体教育+设备提醒SMD 1.61(95%CI 0.75-2.47;P-score 0.914)。

核心结论

  • 网络Meta分析提示定制化护理可改善青光眼用药依从性,多组分方法可能带来额外改善。

研究设计与样本

  • 检索PubMed、EMBASE、Scopus、Cochrane中央对照试验注册库、WHO国际临床试验注册平台和ClinicalTrials.gov,检索日期为2021年11月30日,纳入随机对照试验进行网络Meta分析。
  • 共纳入19项RCT、4981例参与者,比较11类干预(单类或组合):标准治疗(对照)、短信、电话、设备提醒、动机性访谈、多媒体教育、医生教育、提供自身病历、激励、定制化护理和增强标准治疗。
  • 主要结局为干预后平均依从性评分,采用标准化均数差(SMD)分析,以P-score(成为最佳治疗的概率)排序,使用Cochrane随机对照试验偏倚风险工具评价试验,并使用CINeMA评估结果置信度。

主要发现

  • 定制化护理(包括面对面需求评估和个性化护理计划)在改善依从性方面优于标准治疗(SMD 1.28;95%CI 0.08-2.48;P-score 0.810)。
  • 包含定制化护理的多组分干预显示进一步依从性改善:定制化护理+多媒体教育(SMD 1.44;95%CI 0.20-2.67;P-score 0.850)和定制化护理+多媒体教育+设备提醒(SMD 1.61;95%CI 0.75-2.47;P-score 0.914)。
  • 其余干预按P-score排序为:激励(0.606)、短信(0.535)、增强标准治疗(0.458)、多媒体教育(0.430)、设备提醒(0.429)、电话(0.401)、提供自身病历(0.391)、医生教育(0.281)、标准治疗(0.230)、动机性访谈(0.165)。

关键数值与推荐

  • 定制化护理 vs 标准治疗:SMD 1.28(95%CI 0.08-2.48),P-score 0.810。
  • 定制化护理+多媒体教育 vs 标准治疗:SMD 1.44(95%CI 0.20-2.67),P-score 0.850。
  • 定制化护理+多媒体教育+设备提醒 vs 标准治疗:SMD 1.61(95%CI 0.75-2.47),P-score 0.914。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC: Comparative effectiveness of interventions to improve glaucoma medication adherence. CLINICAL RELEVANCE: High adherence to ocular hypotensive therapy is essential for prevention of visual impairment in glaucoma patients. Various types of intervention for adherence enhancement have been proposed, although there is still no firm evidence of their relative efficacies. METHODS: We searched PubMed, EMBASE, Scopus, the Cochrane Central Register of Controlled Trials, the World Health Organization International Clinical Trials Registry Platform, and ClinicalTrials.gov on November 30, 2021. Randomized controlled trials (RCTs) entailing interventions for improved adherence to ocular hypotensive therapy were identified. A network meta-analysis (NMA) was performed, and the following 11 interventions (single category or combinations of categories) were compared: (1) standard of care ([SOC] control), (2) short message service, (3) telephone call, (4) device reminder, (5) motivational interview, (6) multimedia education, (7) physician education, (8) provision of own medical records, (9) incentives, (10) tailored care, and (11) enhanced SOC. The primary outcome was the postintervention mean adherence score. The standardized mean differences (SMDs) were analyzed, and the effectiveness was ranked by P-score (probability of being best treatment). We appraised trials using the Cochrane risk-of-bias tool for RCTs. Confidence of results was assessed by Confidence in Network Meta-analysis. RESULTS: We obtained data for 19 RCTs (4981 participants). Tailored care, as inclusive of face-to-face needs assessment and a personalized care plan, was superior to SOC in improving adherence (SMD, 1.28; 95% confidence interval [CI], 0.08-2.48; P-score, 0.810). Multifaceted interventions that included tailored care showed further adherence improvement: tailored care + multimedia education (SMD, 1.44; 95% CI, 0.20-2.67; 0.850) and tailored care + multimedia education + device reminder (SMD, 1.61; 95% CI, 0.75-2.47; 0.914). The ranking of the remaining interventions by P-scores was as follows: incentives (0.606), short message service (0.535), enhanced SOC (0.458), multimedia education (0.430), device reminder (0.429), telephone call (0.401), provision of own medical records (0.391), physician education (0.281), SOC (0.230), and motivational interview (0.165). CONCLUSIONS: The NMA indicated that tailored care can improve adherence to glaucoma medication compared with SOC. A multifaceted approach might yield additional improvements.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Ha A, Jang M, Shim SR, et al. Interventions for Glaucoma Medication Adherence Improvement: A Network Meta-analysis of Randomized Controlled Trials. Ophthalmology. 2022. PMID: 36028393. doi:10.1016/j.ophtha.2022.06.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。